Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MGI Pharma and SuperGen sign license agreement for Dacogen

Sep. 3, 2004

Satraplatin plus radiation therapy studies in phase I/II trial for NSCLC

Sep. 3, 2004

Scandinavian phase II trial of Alpharadin extended to U.K.

Sep. 2, 2004

IC-MedTech licenses Apatone

Sep. 2, 2004

New mitotic kinesin KSP inhibitors discovered by Merck researchers

Sep. 2, 2004

Takeda develops new metastin derivatives for preventing cancer metastasis

Sep. 2, 2004

Biovitrum acquires oncology project from Karolinska

Sep. 1, 2004

PEP-005 initiates human clinical trials

Sep. 1, 2004

Amgen claims CDK inhibitors and their use

Sep. 1, 2004

Modulators of PDE4, MMP and/or TNF-alpha discovered at Celgene

Sep. 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.